AUTO-UPDATED

Medical company announces program for 'AI-powered prescriptions' in Utah

New York-based Nolla Health has launched a pilot program in Utah, becoming the first U.S. company authorized to use artificial intelligence for issuing initial acne treatment prescriptions.

Key Points

  • The Nolla Derm application allows Utah residents aged 18 and older to receive personalized acne treatment plans and prescriptions after a 15-minute digital intake process.
  • The program is authorized by the Utah Office of Artificial Intelligence Policy and will roll out in three distinct stages with varying levels of physician oversight.
  • Safety protocols require a 95% agreement rate between the AI and human physicians, alongside zero serious adverse events, to progress through the pilot stages.
  • Patients can access the service for $4.99 per month, bypassing traditional dermatologist office visits and associated wait times.
  • The company selected acne treatment for the pilot due to the condition's low-risk profile and extensive clinical evidence.

Why it Matters

This pilot represents a significant regulatory milestone in the integration of artificial intelligence into clinical workflows and patient care. By automating routine prescription processes, the program aims to reduce healthcare costs and improve access for patients who face barriers to traditional dermatology services.
Abcnews.com Published by Mason Leib
Read original